| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |